Cannabis and cannabinoids

JAMA - Journal of the American Medical Association

Volumn 316, Issue 22, 2016, Pages 2424-2425

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; APREPITANT; CANNABIDIOL; CANNABINOID; CANNABIS; CENTRAL DEPRESSANT AGENT; DRONABINOL; NABILONE; NABIXIMOLS; PALONOSETRON; PLACEBO;

AGITATION; ANOREXIA; ANXIETY; ATAXIA; CANCER PAIN; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COGNITIVE DEFECT; CONFUSION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; HUMAN; LACTATION; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; ORTHOSTATIC HYPOTENSION; PREGNANCY; PRIORITY JOURNAL; PSYCHOSIS; SEDATION; SHORT SURVEY; SIDE EFFECT; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

EID: 85007564256     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.11772     Document Type: Short Survey

References (12)

1. National Conference of State Legislatures. State medical marijuana laws. www.ncsl.org/research/health/state-medical-marijuana-laws.aspx. Accessed July 21, 2016.
2. Whiting PF,Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-2473.
3. Wilkie G, Sakr B, Rizack T. Medical marijuana use in oncology: A review. JAMA Oncol. 2016;2:670.
4. Rolapitant (Varubi) for prevention and delayed chemotherapy-induced nausea and vomiting. Med Lett Drugs Ther. 2016;58(1487):17-18.
5. Portenoy RK, Ganae-Motan ED, Allende S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A randomized, placebo-controlled, graded-dose trial. J Pain. 2012; 13(5):438-449.
6. Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA. 2015;313(24): 2474-2483.
7. Yadav V, Bever C Jr, Bowen J, et al. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2014; 82(12):1083-1092.
8. Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15(3):270-278.
9. Friedman D, Devinsky O. Cannabinoids in the treatment of epilepsy. N Engl J Med. 2015;373(11): 1048-1058.
10. Committee on Obstetric Practice. The American College of Obstetricians and Gynecologists. Committee Opinion: Marijuana use during pregnancy and lactation. Number 637, July 2015. www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Marijuana-Use-During-Pregnancy-and-Lactation. Accessed July 21, 2016.
11. Hartman RL, Brown TL, Milavetz G, et al. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem. 2015;61(6):850-869.
12. Inhibitors and inducers of CYP enzymes and P-Glycoprotein. Med Lett Drugs Ther. 2016;58 (1491):e46-e47.